Tumor‐Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities
Advanced Science · 2026-06 · 13 (35)
DOI: 10.1002/advs.202600027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 20.03.2026. Verfasst von Yuehua Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Industries of the Future and School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Spleen, Neoplasms, Tumor Microenvironment, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Financial support was provided by the Key R&D Program of Zhejiang, the Key R&D Program of Zhejiang.
Abstract (Originalsprache)
Despite the transformative impact of cancer immunotherapies such as immune checkpoint blockade, durable clinical responses remain limited. Increasing evidence indicates that antitumor immunity is governed not only by the tumor microenvironment, but also by systemic immune regulation mediated by peripheral immune organs. Among these, the spleen functions as a central blood‐filtering immune hub that integrates immune activation with hematopoietic adaptation. During tumor progression, the spleen undergoes profound remodeling, shifting from a site of immune surveillance to a pro‐tumorigenic immune compartment characterized by pathological extramedullary hematopoiesis, and sustained generation of immunosuppressive cell populations, including myeloid‐derived suppressor cells. Continuous systemic export of these cells reinforces tumor immune evasion and constrains the efficacy of immune checkpoint blockade. In this review, we summarize current understanding of splenic structure and immunological function, delineate the mechanisms driving tumor‐induced splenic remodeling, and examine its role in systemic immunosuppression and resistance to cancer immunotherapy. We further evaluate emerging therapeutic strategies aimed at targeting the spleen, highlighting both their translational potential and key biological barriers. Collectively, this work identifies tumor‐induced splenic remodeling as a central yet underappreciated determinant of immunotherapy response and a promising target for next‐generation immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center for Industries of the Future and School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
- Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
- Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
ORCID-Profile: Xiaofei Gao
Förderung
- Financial support was provided by the Key R&D Program of Zhejiang
- the Key R&D Program of Zhejiang
Zitieren
APA
Liu, Y., Nie, X., & Gao, X. (2026). Tumor‐Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities. Advanced Science, 13(35). https://doi.org/10.1002/advs.202600027
Vancouver
Liu Y, Nie X, Gao X. Tumor‐Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities. Advanced Science. 2026;13(35). doi:10.1002/advs.202600027
BibTeX
@article{Liu2026,
author = {Liu, Yuehua and Nie, Xiaoqian and Gao, Xiaofei},
title = {Tumor‐Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {35},
doi = {10.1002/advs.202600027}
}
EUVIMED